📊 Summary of Our Data Pipeline & Model Results
This was a massive data-building effort that has paid off. Here’s the story of our data and what we found.
What We Did: The Data Pipeline
1.	Hybrid Cohort: We successfully combined two different data sources. We started with the RD_surgeries.csv log (which had reliable proc_name and laterality) and merged it with a much larger, CPT-based cohort from the RD_procedures files.
2.	Smarter Imputation: We created a robust cohort_id -> Eye map (based on "ever-diagnosed" RD) to intelligently impute laterality for the CPT-only data.
3.	New Feature: SurgeryRank: Per your request, we created a SurgeryRank (1, 2, 3...) for every surgery, allowing us to model risk for primary vs. subsequent operations. This expanded our final dataset from 4,334 to 9,301 total surgeries.
4.	Data Enrichment: We fixed major data sparsity issues by relaxing the time windows for VA, which dramatically improved our data, dropping missing VA_LogMAR_PreOp to just 16.7% and VA_LogMAR_6mo to 33.0%.
5.	Feature Engineering: We created new, complex interaction features (like Age_x_Complex and VA_x_Diabetes) to capture non-linear risks.
6.	Advanced Modeling: We used the same method as the STS cardiac team: L1/Lasso Regularization with 10-fold cross-validation. This automatically tests all 34 features and selects only the most statistically predictive ones, giving us a realistic, honest measure of our model's power.
 
What We Found: Final Model Results
1. 90-Day Re-operation (Models 1 & 2)
•	Result: This is our most important scientific finding. The cross-validated AUCs are low (0.576 and 0.559).
•	Interpretation: This is not a failure of our code; it's a finding. It means these pre-operative risk factors are poor predictors of 90-day success. The risk of re-operation is likely driven by factors we are not yet capturing, such as specific anatomic details (e.g., PVR grade, macular status, break location) or intra-operative variables.
•	Key Predictors: The L1/Lasso model did find significant interaction terms like VA_x_Diabetes and Age_x_Complex, proving that risk is complex. It also found RF_is_on_Steroid was a top predictor of success, which is likely confounding (sicker, more closely-watched patients).
2. 6-Month Visual Acuity (Model 3)
•	Result: A strong, successful model.
•	Performance: We achieved a solid, realistic R-squared of 0.1071. This means our features can reliably explain ~11% of the variation in 6-month VA.
•	Key Predictors:
o	VA_LogMAR_PreOp (0.235): The #1 predictor. This confirms: "worse vision in, worse vision out."
o	Diabetes_x_Rank (0.019): A fantastic finding. This interaction term means the negative impact of diabetes on vision gets worse with each subsequent surgery.
o	RF_is_Myopia (-0.060): Myopia was associated with better long-term vision.
3. ERM Complication (Model 4)
•	Result: Our best, most predictive model.
•	Performance: A respectable cross-validated AUC of 0.633. We can confidently identify patients at higher risk for ERM.
•	Key Predictors:
o	Age (0.421): The #1 risk factor by a huge margin.
o	gender_Male (0.147): Males were at higher risk.
o	Interaction Terms: The model selected VA_x_Diabetes, Diabetes_x_Rank, and Pseudophakic_x_PPV, showing that ERM risk is highly complex.
4. Cataract Complication (Model 5)
•	Result: A simple, "smart" model.
•	Performance: The AUC was low (0.56), but the L1/Lasso model did its job perfectly: it threw out 32 of our 34 features and selected only Age and RF_is_Lattice as predictors. This is a clinically perfect, logical result, as Age is the primary driver of cataracts.

